Montelukast sodium for exercise-induced asthma

Drugs of Today

Volumn 44, Issue 11, 2008, Pages 845-855

  De Benedictis, Fernando Maria ^a   Vaccher, Silvia ^a   De Benedictis, Diletta ^b  

^a Salesi Children's Hospital   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; LORATADINE; MONTELUKAST; PLACEBO; SALMETEROL; STEROID; ZAFIRLUKAST; ZILEUTON;

ARTICLE; BRONCHOSPASM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG STRUCTURE; EXERCISE INDUCED ASTHMA; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG GAS EXCHANGE; SPIROMETRY;

ACETATES; ADMINISTRATION, ORAL; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA, EXERCISE-INDUCED; CHILD; CHILD, PRESCHOOL; HUMANS; LEUKOTRIENE ANTAGONISTS; META-ANALYSIS AS TOPIC; MOLECULAR STRUCTURE; QUINOLINES;

EID: 60949094822     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2008.44.11.1297498     Document Type: Article

References (43)

1. Carlsen, K.H., Carlsen, K.C. Exercise-induced asthma. Paediatr Respir Rev 2002, 3(2): 154-60.
2. Gotshall, R.W. Exercise-induced bronchoconstriction. Drugs 2002, 62(12): 1725-39.
3. McFadden, E.R. Jr., Gilbert, I.A. Exercise-induced asthma. N Engl J Med 1994, 330(19): 1362-7.
4. Milgrom, H., Taussig, L.M. Keeping children with exercise-induced asthma active. Pediatrics 1999, 104(3): e38.
5. Lang, D.M., Butz, A.M., Duggan, A.K., Serwint, U.R. Physical activity in urban school-aged children with asthma. Pediatrics 2004, 113(4): e341-6.
6. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma - Summary Report 2007. J Allergy Clin Immunol 2007, 120(Suppl.): S94-138.
7. GINA Executive Committee. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2006. Available at: http://www.ginasthma.org. Accessed December 24, 2008.
8. Weiler, J.M., Bonini, S., Coifman, R. et al.; Ad Hoc Committee of Sports Medicine Committee of American Academy of Allergy, Asthma & Immunology. American Academy of Asthma, Allergy & Immunology Work Group Report: Exercise-induced asthma. J Allergy Clin Immunol 2007,119(6): 1349-58.
9. Bacharier, L.B., Boner, A., Carlsen, K.H. et al.; European Pediatric Asthma Group. Diagnosis and treatment of asthma in childhood: A PRACTALL consensus report. Allergy 2008, 63(1): 5-34.
10. Anderson, S.D., Smith, C.M. Osmotic challenges in the assessment of bronchial hyperresponsiveness. Am Rev Respir Dis 1991, 143(3 Pt. 2): S43-6.
11. McFadden, E.R. Jr. Hypothesis: Exercise-induced asthma as a vascular phenomenon. Lancet 1990, 335(8694): 880-3.
12. Anderson, S.D., Daviskas, E. The mechanism of exercise-induced asthma is ellipsis. J Allergy Clin Immunol 2000, 106(3): 453-9.
13. Peters-Golden, M., Henderson, W.R. Leukotrienes. N Engl J Med 2007, 357(18): 1841-54.
14. O'Byrne, P.M. Leukotriene bronchoconstriction induced by allergen and exercise. Am J Respir Crit Care Med 2000, 161(2 Pt. 2): S68-72.
15. 4 levels after allergen and exercise challenge in bronchial asthma. Am Rev Respir Dis 1991, 144(6): 1411-3.
16. 4 after exercise challenge in children with asthma. J Allergy Clin Immunol 1992, 89(6): 1111-9.
17. 4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997, 52(12): 1030-5.
18. Carraro, S., Corradi, M., Zanconato, S. et al. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005, 115(4): 764-70.
19. Storms, W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opin Pharmacother 2007, 8(1): 1-14.
20. Knorr, B., Holland, S., Schwartz, J., Rogers, J.D., Reiss, T. F. Clinical pharmacology of montelukast. Clin Exp Allergy Rev 2001, 1: 254-60.
21. Bronsky, E.A., Kemp, J.P., Zhang, J., Guerriero, D., Reiss, T.F. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval. Clin Pharmacol Ther 1997, 62(5): 556-61.
22. Left, J.A., Busse, W.W., Pearlman, D. et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998, 339(3): 147-52.
23. Pearlman, D.S., van Adelsberg, J., Philip, G. et al. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol 2006, 97(1): 98-104.
24. Philip, G., Villarán, C., Pearlman, D.S., Loeys, T., Dass, S.B., Reiss, T.F. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast. J Asthma 2007, 44(3): 213-7.
25. 2-agonists, leukotriene receptor antagonists, and 5-lipoxygenase inhibitor on exercise-induced asthma. J Allergy Clin Immunol 2000, 106(3): 500-6.
26. Philip, G., Pearlman, D.S., Villarán, C. et al. Singledose montelukast or salmeterol as protection against exercise-induced bronchoconstriction. Chest 2007, 132(3): 875-83.
27. Villarán, C., O'Neill, S.J., Helbling, A. et al. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. J Allergy Clin Immunol 1999, 104(3 Pt. 1): 547-53.
28. Edelman, J.M., Turpin, J.A., Bronsky, E.A. et al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. Ann Int Med 2000, 132(2): 97-104.
29. 2-Agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 2002, 165(8): 1068-70.
30. Storms, W., Chervinsky, P., Ghannam, A.F., Bird, S., Hustad, C.M., Edelman, J.M.; Challenge-Rescue Study Group. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir Med 2004, 98(11): 1051-62.
31. Ringsted, C.V., Eliasen, K., Anderson, J.B. et al. Ventilation- perfusion distributions and central hemodynamics in chronic obstructive pulmonary disease: Effects of terbutaline administration. Chest 1989, 96(5): 976-83.
32. Steinshamn, S., Sandsund, M., Sue-Chu, M,, Bjermer, L. Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction. Chest 2004, 126(4): 1154-60.
33. Szczeklik, A., Sladek, K., Dworski, R. et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin sensitive asthmatics. Am J Respir Crit Care Med 1996, 154(6 Pt. 1): 1608-14.
34. Mastalerz, L., Gawlewicz-Mroczka, A., Nizankowska, E., Cmiel, A., Szczeklik, A. Protection against exer cise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma. Clin Exp Allergy 2002, 32(9): 1360-5.
35. Kemp, J.P., Dockhorn, R.J., Shapiro, G.G. et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr 1998, 133(3): 424-8.
36. Peroni, D.G., Piacentini, G.L., Ress, M. et al. Time efficacy of a single dose of montelukast on exercise-induced asthma in children. Pediatr Allergy Immunol 2002, 13(6): 434-7.
37. Peroni, D.G., Piacentini, G.L., Pietrobelli, A. et al. The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children. Eur Respir J 2002, 20(1): 104-7.
38. Pajaron-Fernandez, M., Garcia-Rubia, S., Sanchez-Solis, M., Garcia-Marcos, L. Montelukast administered in the morning or evening to prevent exercise-induced bronchoconstriction in children. Pediatr Pulmonol 2006, 41(3): 222-7.
39. Melo, R.E., Solé, D., Naspitz, C.K. Exercise-induced bronchoconstriction in children: Montelukast attenua tes the immediate-phase and late-phase responses. J Allergy Clin Immunol 2003, 111(2): 301-7.
40. Kim, J.H., Lee, S.Y., Kim, H.B. et al. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction. Pediatr Pulmonol 2005, 39(2): 162-6.
41. de Benedictis, P.M., del Giudice, M.M., Forenza, N., Decimo, F., de Benedictis, D., Capristo, A. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children. Eur Respir J 2006, 28(2): 291-5.
42. Vidal, C., Fernández-Ovide, E., Piñeiro, J., Nuñez, R., González-Quintela, A. Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction. Ann Allergy Asthma Immunol 2001, 86(6): 655-8.
43. Stelmach, I., Grzelewski, T., Majak, P., Jerzynska, J., Stelmach, W., Kuna, P. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol 2008, 121(2): 383-9.